Spur Therapeutics
Developing gene therapies for diseases
- B2B
About Spur Therapeutics
A biotechnology company developing gene therapies for chronic diseases by delivering therapeutic genes into liver cells, advancing treatments for Gaucher disease and Parkinson's
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Stevenage, England, United Kingdom
- Founded
- 2015
- Revenue
- $18.6M – $147MTamtam estimate
- Website
- spurtherapeutics.com
Spur Therapeutics at a glance
Spur Therapeutics is a B2B company in the Biotechnology Research industry, headquartered in Stevenage, England, United Kingdom.
Spur Therapeutics was founded in 2015.
Spur Therapeutics has 251–1,000 employees.
Spur Therapeutics's revenue is $18.6M – $147M (Tamtam estimate).
Frequently asked questions about Spur Therapeutics
What is Spur Therapeutics's revenue?
Tamtam estimates Spur Therapeutics's annual revenue at $18.6M – $147M.
How many employees does Spur Therapeutics have?
Spur Therapeutics has 251–1,000 employees.
Where is Spur Therapeutics headquartered?
Spur Therapeutics is headquartered in Stevenage, England, United Kingdom.
Selling to companies like Spur Therapeutics?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies